Quarterly report [Sections 13 or 15(d)]

Stock-based Compensation (Tables)

v3.25.2
Stock-based Compensation (Tables)
9 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Schedule of Stock-Based Compensation
Restricted Stock Awards (“RSAs”)
Restricted Stock Awards Shares Weighted-
Average
Grant Date
Fair Value
Outstanding at September 30, 2024 17,500 $ 37.82 
Vested (8,750) 37.82 
Outstanding at June 30, 2025 (a) 8,750 $ 37.82 
a.The remaining contractual term is 0.5 years and the aggregate intrinsic value of RSAs expected to vest is $286.
Stock Option Grants
Number of
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
(years)
Aggregate
Intrinsic
Value
Vested and outstanding - June 30, 2025 38,000 $ 33.75  1.5
On December 23, 2024, the Company granted MRSUs to one of its executives, which will be eligible to be earned if at any time prior to September 30, 2027, the average 30-day closing per share price of the Company’s Common Stock exceeds the applicable price per share thresholds set forth below:

Price Per Share Threshold
Number of MRSUs Earned
$35 per share
5,000
$40 per share
12,500
$45 per share
20,500
The assumptions used in the Monte Carlo simulation model to calculate the fair value of the Company’s MRSUs are as follows:

Nine months ended
June 30, 2025
Expected volatility of stock price 33.14  %
Risk-free interest rate 4.26  %
Expected term of awards (years) 2.77
Dividend yield 0.76  %
Grant date stock price $ 26.15 
Market-based Restricted Stock Units Shares Weighted-
Average
Grant Date
Fair Value
Outstanding at September 30, 2024 —  $ — 
Granted 38,000 $ 12.32 
Vested —  $ — 
Forfeited —  $ — 
Outstanding at June 30, 2025 (a) 38,000 $ 12.32 
a.The weighted average remaining contractual term is 2.8 years and the aggregate intrinsic value of MRSUs expected to vest is $1,134.